For millions of people who trusted Philips Respironics CPAP and BiPAP machines to help them breathe safely each night, the resolution of the Philips CPAP litigation marks an important milestone in one of the largest medical device cases in recent years.
Philips CPAP Settlement Reaches Payment Phase
In 2025, plaintiffs reached a landmark $1.075 billion settlement with Philips to resolve thousands of personal injury claims alleging that recalled Philips CPAP, BiPAP, and ventilator devices caused serious injuries and, in some cases, death. Childers, Schlueter & Smith (CSS) is proud to have represented numerous clients who have received—or are expected to receive—compensation through this settlement.
The litigation stemmed from Philips’ June 2021 recall of approximately 5.5 million CPAP, BiPAP, and ventilator devices after concerns emerged that the polyester-based polyurethane (PE-PUR) foam used for sound abatement could degrade over time, potentially releasing particles and volatile organic compounds that users could inhale or ingest. The recall prompted extensive investigations by the U.S. Food and Drug Administration and generated more than 105,000 adverse event reports.
Importantly, this settlement is no longer simply an announced agreement. The claims administration and distribution process entered the payment phase in early 2026, and eligible claimants are now receiving compensation.
For many individuals and families, these payments represent the culmination of years of litigation seeking accountability for injuries allegedly caused by defective medical devices. While no settlement can undo the harm suffered by injured patients or families who lost loved ones, the resolution provides meaningful compensation and closes an important chapter in this nationwide litigation.
CSS Represents Patients Harmed by Defective Medical Devices
Childers, Schlueter & Smith remains committed to representing individuals harmed by defective medical devices and dangerous pharmaceutical products. Attorney Jed Douglas has led the firm’s Philips CPAP litigation, working closely with clients throughout the claims process and helping them navigate this complex nationwide settlement.
Philips has denied liability and has not admitted wrongdoing as part of the settlement. Certain claims and related litigation remain pending.
If you or a loved one has been seriously injured by a defective medical device, Childers, Schlueter & Smith can help you understand your legal options. Our attorneys represent individuals and families in complex product liability and mass tort cases involving dangerous medical devices and pharmaceutical products.
Contact us online, via live chat, or by calling 1-800-641-0098 to speak with our team.
About the Author: Jed Douglas is an attorney with Childers, Schlueter & Smith, LLC, where he leads the firm’s Philips CPAP litigation. He represents individuals injured by defective medical devices and dangerous pharmaceutical products in complex mass tort and product liability cases.
Other Medical Devices News
The FDA warns that Synovo Total Hip Systems, implanted after 2019, pose risks of failure and injury. Patients experiencing symptoms should consult our CSS lawyers to explore legal options for compensation.
Thousands of hernia mesh products have been recalled, but qualifying for a claim requires proof that a defective hernia mesh implant caused your injury.
Damages from a defective hernia mesh implant vary based on each person’s injuries and circumstances. An experienced dangerous medical device attorney can help identify all the losses you may be entitled to recover.
Women nationwide are filing lawsuits after suffering injuries from Paragard IUD breakage—alleging the manufacturer failed to warn of the device’s dangerous design defects.
A voluntary recall affects over 3.5 million Philips Respironics CPAP, BiPAP, and ventilator devices due to foam degradation risks, potentially endangering sleep apnea patients’ health and safety.
Philips Respironics has recalled certain CPAP, BiPAP, and ventilator devices due to degrading sound foam that may release harmful particles and chemicals, posing serious health risks to users.
